Novavax signs manufacturing deal with Endo for potential Covid-19 vaccine

Representative image. Credit: iStock

Novavax Inc has signed an agreement with Endo International for manufacturing its experimental Covid-19 vaccine, the generic drugmaker said on Friday.

Endo said its unit Par Sterile has begun production of the final drug product, with initial batches to be used in Novavax's phase-3 clinical trial in the United States.

Deccan Herald is on WhatsApp Channels | Join now for Breaking News & Editor's Picks